The contribution of gluconeogenesis to hepatic glucose production (GP) was quantified after 2 H 2 O ingestion by Bayesian analysis of the position 2 and 5 2 H-NMR signals (H2 and H5) of monoacetone glucose (MAG) derived from urinary acetaminophen glucuronide. Six controls and 10 kidney transplant (KTx) patients with cyclosporine A (CsA) immunosuppressant therapy were studied. Seven KTx patients were lean and euglycemic (BMI ؍ 24.3 ؎ 1.0 kg/m 2 ; fasting glucose ؍ 4.7 ؎ 0.1 mM) while three were obese and hyperglycemic (BMI ؍ 30.5 ؎ 0.7 kg/m 2 ; fasting glucose ؍ 7.1 ؎ 0.5 mM). For the 16 spectra analyzed, the mean coefficient of variation for the gluconeogenesis contribution was 10% ؎ 5%. This uncertainty was associated with a mean signal-to-noise ratio (SNR) of 79:1 and 45:1 for the MAG H2 and H5 signals, respectively. For control subjects, gluconeogenesis contributed 54% ؎ 7% of GP as determined by the mean and standard deviation (SD) of individual Bayesian analyses. For the lean/normoglycemic KTx subjects, the gluconeogenic contribution to GP was 62% ؎ 7% (P ؍ 0.06 vs. controls), while hyperglycemic/obese KTx patients had a gluconeogenic contribution of 68% ؎ 3% (P < 0.005 vs. controls). These data suggest that in KTx patients, an increased gluconeogenic contribution to GP is strongly associated with obesity and hyperglycemia. Plasma glucose levels are maintained over the daily feeding/fasting cycle through tight coordination of glucose appearance and disposal. During overnight fasting, glucose appearance is entirely accounted for by endogenous glucose production (GP) once digestive absorption has ceased. The occurrence of hyperglycemia after overnight fasting is a hallmark of defective glucose metabolism and indicates a mismatch between GP and plasma glucose clearance. Impaired glucose uptake by peripheral tissues and inappropriately high levels of hepatic GP can both contribute to this condition. Among other things, resolving these underlying defects could prove useful for guiding and evaluating interventions of fasting hyperglycemia, since some antihyperglycemic medications act by inhibiting GP while others function by improving whole-body glucose uptake.Systemic glucose metabolism is typically assessed in the clinical setting by quantifying plasma glucose levels before and after an oral glucose load, but this approach does not provide any information about hepatic glucose metabolism. Assessment of GP with stable-isotope tracers could provide useful information to complement measurements of plasma glucose clearance; however, current methods are poorly suited for routine clinical studies. This is due to several factors, including high tracer cost, the requirement of lengthy infusion times for administration of the tracer, and extensive sample processing and analysis. Deuterated water ( 2 H 2 O) is an inexpensive tracer of gluconeogenesis that can be administered orally and is therefore well suited for routine clinical study procedures. The metabolic information is derived from the analysis of the 2...